u-0126 and Cognition-Disorders

u-0126 has been researched along with Cognition-Disorders* in 2 studies

Other Studies

2 other study(ies) available for u-0126 and Cognition-Disorders

ArticleYear
Inhibition of MAPK/ERK signaling blocks hippocampal neurogenesis and impairs cognitive performance in prenatally infected neonatal rats.
    European archives of psychiatry and clinical neuroscience, 2015, Volume: 265, Issue:6

    Hippocampus endogenous neurogenesis has been postulated to play a favorable role in brain restoration after injury. However, the underlying molecular mechanisms have been insufficiently deciphered. Here we investigated the potential regulatory capacity of MAPK/ERK signaling on neurogenesis and the associated cognitive performance in prenatally infected neonatal rats. From our data, intrauterine infection could induce hippocampal neuronal apoptosis and promote endogenous repair by evoking neural stem cell proliferation and survival. We also found intrauterine infection could induce increased levels of p-ERK, p-CREB and BDNF, which might be responsible for the potential endogenous rescue system. Furthermore, inhibition of MAPK/ERK signaling could aggravate hippocampal neuronal apoptosis, decrease neurogenesis, and impair the offspring's cognitive performances and could also down-regulate the levels of p-ERK, p-CREB and BDNF. Our data strongly suggest that the activation of MAPK/ERK signaling may play a significant role in promoting survival of newly generated neural stem cells via an anti-apoptotic mechanism, which may be particularly important in endogenous neuroprotection associated with cognitive performance development in prenatally infected rats.

    Topics: Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain-Derived Neurotrophic Factor; Butadienes; Cognition Disorders; Cyclic AMP Response Element-Binding Protein; Enzyme Inhibitors; Escherichia coli Infections; Extracellular Signal-Regulated MAP Kinases; Female; Hippocampus; MAP Kinase Signaling System; Neurogenesis; Neurons; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Rats

2015
Inhibition of extracellular signal-regulated kinase activity improves cognitive function in Tg2576 mice.
    Clinical and experimental pharmacology & physiology, 2012, Volume: 39, Issue:10

    1. Deposition of β-amyloid (Aβ) peptide is a defining pathological hallmark of Alzheimer's disease (AD) and is involved in memory impairment. Evidence suggests that activation of an extracellular signal-regulated kinase (ERK) pathway is related to Aβ accumulation. Thus, the aim of the present study was to investigate the effects of an ERK inhibitor (U0126) on amyloidogenesis and cognitive function in Tg2576 mice. 2. Tg2576 mice were injected with U0126 (20 mg/kg, i.p.) or vehicle (1% dimethyl sulphoxide in sterile saline) once a day for 7 days and then cognitive function was assessed by the Morris water maze test and passive avoidance test. In addition, immunostaining, western blot analysis, ELISA and enzyme activity assays were used to examine the degree of Aβ deposition in the brains of Tg2576 mice. 3. Our results showed that U0126 attenuated memory impairment and inhibited Aβ deposition in the brains of Tg2576 mice. Further experiments revealed that the inhibition of Aβ deposition by U0126 was due to a reduction in β-secretase and amyloid precursor protein expression in the brains of U0126-treated Tg2576 mice. 4. These results suggest that the ERK pathway is associated with Aβ accumulation and consequent memory dysfunction in Tg2576 mice and that inhibition of the ERK pathway may be an appropriate intervention in the treatment of AD.

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain; Butadienes; Cognition Disorders; Extracellular Signal-Regulated MAP Kinases; Female; Memory Disorders; Mice; Mice, Transgenic; Nitriles

2012